Use Of Azasetron For The Treatment Of Rosacea, And Pharmaceutical Compositions


The invention relates to the use of azasetron or the salts thereof as an active substance in a pharmaceutical composition, especially a dermatological composition. The composition is preferably topically applied and is used for the treatment and/or prevention of rosacea.

Download PDF
Document Preview
Document History
  • Publication: Dec 6, 2007
  • Application: May 31, 2007
    WO FR 2007051362 W
  • Priority: May 31, 2006
    FR FR 0651985 A

Sign in to the Lens